Boston Scientific Gets FDA Approval For Precision Montage MRI Spinal Cord Stimulator System

Boston Scientific Corporation BSX revealed Thursday that the FDA in the United States has given its approval for its Precision Montage MRI Spinal Cord Stimulator System. Following this, the company has launched the device that offered customized relief to patients, who are suffering with chronic pain.

According to the company, the device also enables safe access to full body magnetic resonance imaging (MRI) in a 1.5 Tesla environment when conditions of use were met. Boston Scientific indicated that it would launch the system at the 8th World Congress of the World Institute of Pain in New York City on May 20-23.

The medical device maker's SVP and President for Neuromodulation, Maulik Nanavaty, commented, "The Precision Montage MRI SCS System is a key addition to our Illumina 3D portfolio, offering patients more choices to manage and personalize their therapy. This important advancement underscores our commitment to meet the individual needs of chronic pain patients."

Reacting to the developments, Program Director in University Hospital of Cleveland, Ohio, Salim Hayek, said, "The Boston Scientific Illumina 3D portfolio allows me to tailor therapy for each patient consistently and effectively. With the approval of the Precision Montage MRI SCS System, more of my patients can benefit from this powerful technology since they can now have access to future MRI scan needs."

Boston Scientific said that over 100 million Americans suffer from chronic pain, which could have a devastating impact on quality of life. The company added that patients with pain sometimes experience a fluctuation in location, type and intensity of pain throughout the day or over time.

The company said its Precision Montage MRI SCS System enables patients to undergo a full-body MRI while benefiting from the pain relief of MultiWave Technology. Its MultiWave Technology also allows delivery of multiple waveforms, including burst and higher rates, intended to help respond to changes in pain over time. In an interesting analysis of registry information from 800 patients, the company pointed out that 72 percent used multiple waveforms to customize their therapy and optimize pain relief.